Home › NDC Lookup › RxCUI directory › RxCUI 1865942

Menthol 0.1 MG/MG Topical Gel [Stopain] — RxCUI 1865942

RxNorm drug concept · Semantic branded drug
RxCUI 1865942 Semantic branded drug · SBD ● Current RxNorm concept 7 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1865942
Official nameMenthol 0.1 MG/MG Topical Gel [Stopain]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asStopain 10 % Topical Gel; Stopain CLINICAL 10 % Topical Gel; Stopain 0.1 MG/MG Topical Gel
FDA products mapped7
Package NDCs mapped11
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Menthol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Menthol is found in a lot of over-the-counter topical products — creams, gels, patches, sprays, and powders. Depending on the product, it's used to temporarily ease minor muscle an...
  • Start with clean, dry skin — free of lotions or creams — before applying the patch. Peel the backing off and press the sticky side firmly to the sore area. Most menthol patches sho...
  • Yes, a mild burning or tingling feeling right after applying a menthol product is common and usually settles down within a few days of regular use. What's not normal is severe burn...
  • Is that burning sensation after I apply it normal?
📖 Read our full Menthol guide →

🕸️ Concept Web — How Menthol 0.1 MG/MG Topical Gel [Stopain] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Menthol 0.1 MG/MG Topical Gel [Stopain] RxCUI 1865942

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Menthol 6750
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Stopain 220038
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Menthol Topical Gel 311514
    • Menthol Topical Product 1160376
    • Menthol Topical Gel [Stopain] 1048311
    • Stopain Topical Product 1180204
    • Topical Gel 346286
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Menthol 0.1 MG/MG Topical Gel SCD · 259249
  • Menthol 0.1 MG/MG SCDC · 384557
  • Menthol Topical Gel SCDF · 311514
  • Menthol Topical Product SCDG · 1160376

Brand-Name Concepts

  • Menthol 0.1 MG/MG [Stopain] SBDC · 1865941
  • Menthol Topical Gel [Stopain] SBDF · 1048311
  • Stopain Topical Product SBDG · 1180204
  • Stopain BN · 220038

📦 FDA Products & Package NDCs

7 products · 11 package NDCs
11 package NDCs map to RxCUI 1865942 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42961-0256-01 3 g in 1 PACKET (42961-256-01) Xpect Stopain Clinical Cintas Corporation 2025-07-30
42961-0256-02 5 PACKET in 1 BAG (42961-256-02) / 3 g in 1 PACKET (42961-2... Xpect Stopain Clinical Cintas Corporation 2025-07-30
63936-0975-05 5 g in 1 PACKET (63936-0975-5) Stopain Clinical Troy Manufacturing, Inc. 2017-01-19
63936-9505-05 50 mL in 1 BOTTLE, PUMP (63936-9505-5) Stopain Clinical Troy Manufacturing, Inc. 2021-08-09
63936-9520-01 88 mL in 1 BOTTLE (63936-9520-1) Stopain Clinical Roll-On Troy Manufacturing, Inc. 2017-01-18
63936-9750-01 3785 mL in 1 BOTTLE (63936-9750-1) Stopain Clinical Troy Manufacturing, Inc. 2017-01-18
63936-9750-02 946 mL in 1 BOTTLE (63936-9750-2) Stopain Clinical Troy Manufacturing, Inc. 2017-01-18
63936-9750-03 118 mL in 1 TUBE (63936-9750-3) Stopain Clinical Troy Manufacturing, Inc. 2017-01-18
63936-9750-04 473 mL in 1 BOTTLE (63936-9750-4) Stopain Clinical Troy Manufacturing, Inc. 2017-01-18
63936-9751-01 12 PACKET in 1 BOX (63936-9751-1) / 3 g in 1 PACKET Stopain Clinical Troy Manufacturing, Inc. 2023-01-31
63936-9758-01 3 g in 1 PACKET (63936-9758-1) Stopain Clinical Troy Manufacturing, Inc. 2022-11-30
Observed labelers: Troy Manufacturing, Inc. (9) · Cintas Corporation (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.